Cosmetic neurology: For physicians the future is now

Virtual Mentor

Volumn 6, Issue 8, 2004, Pages 368-371

  Chatterjee, Anjan ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84974526581     PISSN: 19377010     EISSN: None     Source Type: Journal    
DOI: 10.1001/virtualmentor.2004.6.8.oped1-0408     Document Type: Article

References (26)

1. Groopman J. Eyes wide open. The New Yorker. December 3, 2001. 52-57. View Article PubMed Google Scholar
2. Marcus S. Neuroethics: Mapping the Field. New York: Dana Press; 2002. Google Scholar
3. Rose S. Smart drugs: do they work, will they be legal? Nature Reviews Neuroscience. 2002;3:975-979. View Article PubMed Google Scholar
4. The ethics of brain science: open your mind. The Economist. May 25, 2002; 77-79.
5. Farah MJ. Emerging ethical issues in neuroscience. Nature Neuroscience. 2002;5:1123-1129. View Article PubMed Google Scholar
6. Wolpe P. Treatment, enhancement, and the ethics of neurotherapeutics. Brain and Cognition. 2002;50:387-305. View Article PubMed Google Scholar
7. Plotz D. The ethics of enhancement. Slate. March 12, 2003. Accessed July 27, 2004.
8. Elliot C. American bioscience meets the American dream. The American Prospect. 2003;14:38-42. Google Scholar
9. President's Council on Bioethics. Beyond Therapy: Biotechnology and the Pursuit of Happiness. Washington, DC; President's Council on Bioethics. 2003. Accessed July 27, 2004. Google Scholar
10. Baily R. The battle for your brain. Reasononline. February 2003. Accessed July 26, 2004.
11. Whitehouse P, Juengst E, Mehlman M, Murray T. Enhancing cognition in the intellectually intact. Hastings Center Report. 1997;27 (May-June):14-22. View Article PubMed Google Scholar
12. Chatterjee A. Cosmetic neurology: the controversy over enhancing movement, mentation and mood. Neurology. 2004 (in press). View Article PubMed Google Scholar
13. Daniels N. Normal functioning and the treatment-enhancement distinction. Cambridge Quart Healthcare Ethics. 2000;9:309-322. PubMed Google Scholar
14. Fukayama F. Our Posthuman Future. New York: Farrar, Straus & Giroux, 2002. Google Scholar
15. Cuttler L, Silvers J, Singh J, et al. Short stature and growth hormone therapy: a national study of physician recommendation patterns. JAMA. 1996;276: 531-537. View Article PubMed
16. Harris Interactive. Inc. The impact of Parkinson's disease on quality of life. Online Survey. 2003.
17. Nortvedt M, Riise T. The use of quality of life measures in multiple sclerosis research. Multiple Sclerosis. 2003;9:63-72. View Article PubMed Google Scholar
18. Solomon P, Adams F, Silver A, Zimmer J, DeVeaux R. Ginkgo for memory enhancement: a randomized controlled trial. JAMA. 2002;288:835-840. View Article PubMed Google Scholar
19. Langreth R. Viagra for the brain. Forbes. February 4, 2002: 46-52. Google Scholar
20. Hall S. The quest for a smart pill. Scientific American. 2003;289:54-65. PubMed Google Scholar
21. George M. Stimulating the brain. Scientific American. 2003;289:67-77. View Article Google Scholar
22. Caldwell JJ, Caldwell J, Smythe NR, Hall K. A double-blind, placebo-controlled investigation of the efficacy of modafinil for sustaining the alertness and performance of aviators: a helicopter simulator study. Psychopharmacology. 2000;150:272-282. View Article PubMed Google Scholar
23. Elliot C. Better than Well: American Medicine Meets the American Dream. New York: WW Norton & Company; 2003. Google Scholar
24. Kass L. The pursuit of biohappiness. Washington Post. October 16, 2003: A25. PubMed Google Scholar
25. Schneider C. The Practice of Autonomy: Patients, Doctors and Medical Decisions. New York: Oxford Press; 1998. Google Scholar
26. Schwartz B. The Paradox of Choice: Why Less Is More. New York: Ecco, 2004. Google Scholar